Long-term follow-up after ultrathin vs. conventional 2nd-generation drug-eluting stents: a systematic review and meta-analysis of randomized controlled trials.
Mahesh V MadhavanJames Philip HowardAzim NaqviOri Ben-YehudaBjorn RedforsMegha PrasadBahira ShahimMartin B LeonSripal BangaloreGregg W StoneYousif AhmadPublished in: European heart journal (2021)
At a mean follow-up of 2.5 years, ultrathin-strut DES reduced the risk of TLF, driven by less CD-TLR compared with conventional 2nd-generation thin-strut DES, with similar risks of MI, ST, cardiac death, and all-cause mortality.